Proactive research analyst John Savin speaks to Thomas Warner after publishing a new report on Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF), in which he looks ahead to what investors can expect from the business on the clinical side during 2023.
Savin gives the highlights from the report and discusses the company's financial position.